What is Active Ingredient Prescribing?
If you prescribe medicines for your patients regularly you may have heard about the upcoming Active Ingredient Prescribing (AIP) government initiative. We are extremely excited to announce that we are very close to releasing an update for Gentu which will comply with AIP in time for the 1 February 2021 mandate.
The goal of Active Ingredient Prescribing is to ensure consistent and standardised medicines information on prescriptions by stating the active ingredients of the drug, ultimately providing patients with the means to assess and understand what active ingredients they are being prescribed.
Patients will be able to easily identify the active ingredients they are prescribed, with the aim of reducing the risk of people taking multiple doses of the same active ingredient from differently branded medicines.
What does this mean for my practice?
Our developers will update your Gentu software before the 1 February 2021 mandate, meaning your prescribers will automatically be compliant with this new government legislation!
This update will contain a software change that means all active ingredient names will be listed when your prescribers are preparing prescriptions for Pharmaceutical Benefits Scheme (PBS) or Repatriation PBS (RPBS) medicines. This will mean most medicines will be prescribed by their active ingredient, not the brand name.
The Department of Health has changed legislation to require the inclusion of active ingredients on all PBS and RPBS prescriptions, except for:
- Handwritten prescriptions;
- Paper based medication charts in the residential aged care sector;
- Medicinal items with four or more active ingredients;
- Other items excluded for safety or practicality reasons.
Where can I find more information?
For more information and PDF support materials, please see the Department of Health's webpage below.